The Keck School of Medicine of USC has joined the Ryght Research Network, a global network of academic institutions, community practices and health care systems that uses generative artificial intelligence to make clinical trials more efficient. As the network’s first academic site in the United States, the Keck School of Medicine will leverage the collaboration to offer more clinical trials to more patients and to build new AI tools that safely speed up the process of developing medical treatments. The alliance between medical school and Ryght AI was brokered by MESH Strategic Partnerships, a specialized service that builds and sustains relationships between the Keck School of Medicine and industry groups. In addition to streamlining the process of conducting clinical trials, the Ryght Research Network will connect USC researchers with new clinical trial and sponsorship opportunities. It will also provide patients and health care providers with a user-friendly portal for exploring available clinical trials. Down the line, the Keck School of Medicine will even have the chance to develop customized AI-driven tools that suit the needs of its patients, providers and investigators.

The Technion-Israel Institute of Technology will award the Harvey Prize in Science and Technology to Prof. Stephen Baylin, Prof. Peter Jones, and Prof. Andrew Feinberg for their groundbreaking work in cancer epigenetics.The Harvey Prize, the Technion’s most prestigious award, was established in 1971 by industrialist and inventor Leo Harvey (1887–1973), a devoted friend of the Technion and the State of Israel. The prize is awarded annually for outstanding achievements in science, technology, and human health, and for significant contributions to humanity. Over the years, the prize has earned a reputation as a “Nobel predictor,” with more than 30% of recipients subsequently winning the Nobel Prize.